Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1978 1
1983 1
1984 2
1986 1
1987 1
1990 2
1991 2
1992 1
1994 3
1995 3
1996 3
1997 1
1998 1
1999 1
2000 3
2003 1
2005 3
2006 1
2007 2
2009 1
2010 4
2011 7
2012 2
2013 6
2014 1
2015 1
2016 4
2017 1
2018 4
2019 1
2020 2
2021 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Skin lymphangioma"
Page 1
Dermatologic Sequelae Associated with Radiation Therapy.
Ashack KA, Kuritza V, Visconti MJ, Ashack L. Ashack KA, et al. Am J Clin Dermatol. 2020 Aug;21(4):541-555. doi: 10.1007/s40257-020-00519-x. Am J Clin Dermatol. 2020. PMID: 32410134 Review.
The most commonly reported cutaneous sequelae associated with radiation therapy include radiation dermatitis, non-melanoma skin cancer, radiation-associated angiosarcoma, morphea, bullous pemphigoid, lymphangioma circumscriptum, and pseudosclerodermatous panniculiti …
The most commonly reported cutaneous sequelae associated with radiation therapy include radiation dermatitis, non-melanoma skin cance …
Vascular and lymphatic tumors in infancy, childhood and adulthood: challenge of diagnosis and treatment.
Edgerton MT, Hiebert JM. Edgerton MT, et al. Curr Probl Cancer. 1978 Jan;2(7):1-44. doi: 10.1016/s0147-0272(78)80001-4. Curr Probl Cancer. 1978. PMID: 373997 Review.
The classification system of hemangiomas presented in this monograph is based upon the clinical prognosis of the angioma. The principles of treatment for hemangiomas based upon our clinical classification are discussed and may be summarized as follows: 1. ...
The classification system of hemangiomas presented in this monograph is based upon the clinical prognosis of the angioma. The princip …
Computed Tomography Image Characteristics before and after Interventional Treatment of Children's Lymphangioma under Artificial Intelligence Algorithm.
Yin C, Wang S, Pan D. Yin C, et al. Comput Math Methods Med. 2021 Dec 9;2021:2673013. doi: 10.1155/2021/2673013. eCollection 2021. Comput Math Methods Med. 2021. Retraction in: Comput Math Methods Med. 2023 Nov 1;2023:9802067. doi: 10.1155/2023/9802067. PMID: 34925537 Free PMC article. Retracted.
At the same time, the Dice similarity coefficient (DSC) of the CNN algorithm was 0.9, which had a higher degree of agreement. In terms of clinical symptoms, the cured children's lesions disappeared, the skin surface returned to normal color, and the treatment was sm …
At the same time, the Dice similarity coefficient (DSC) of the CNN algorithm was 0.9, which had a higher degree of agreement. In terms of …
Inconsistent immunohistochemical expression of lymphatic and blood endothelial cell markers in cutaneous lymphangiomas.
Bhawan J, Silva C, Taungjaruwinai WM. Bhawan J, et al. J Cutan Pathol. 2013 Sep;40(9):801-6. doi: 10.1111/cup.12184. Epub 2013 Jun 20. J Cutan Pathol. 2013. PMID: 23782346 Clinical Trial.
PURPOSE: We sought to describe expression of the immunohistochemical markers, CD31, D2-40 and LYVE-1 (lymphatic vessel hyaluronan receptor-1), that may assist in differentiating cutaneous lymphangioma and cutaneous hemangioma. METHODS: Immunohistochemical staining of ly …
PURPOSE: We sought to describe expression of the immunohistochemical markers, CD31, D2-40 and LYVE-1 (lymphatic vessel hyaluronan receptor-1 …
Highly selective electrocoagulation therapy: an innovative treatment for lymphangioma circumscriptum.
Yang X, Jin Y, Chen H, Li S, Ma G, Hu X, Qiu Y, Yu W, Chang L, Wang T, Lin X. Yang X, et al. Dermatol Surg. 2014 Aug;40(8):899-905. doi: 10.1111/dsu.0000000000000061. Dermatol Surg. 2014. PMID: 24978646
BACKGROUND: Lymphangioma circumscriptum (LC) is a type of microcystic lymphatic malformation involving the skin and mucosa that presents as translucent vesicles of varying size with a pink, red, or black hue. Lymphangioma circumscriptum causes not only cosmet …
BACKGROUND: Lymphangioma circumscriptum (LC) is a type of microcystic lymphatic malformation involving the skin and mucosa tha …
Carbon dioxide laser for the treatment of microcystic lymphatic malformations (lymphangioma circumscriptum): a systematic review.
Savas JA, Ledon J, Franca K, Chacon A, Zaiac M, Nouri K. Savas JA, et al. Dermatol Surg. 2013 Aug;39(8):1147-57. doi: 10.1111/dsu.12220. Epub 2013 Apr 22. Dermatol Surg. 2013. PMID: 23607875 Review.
BACKGROUND: Lymphangioma circumscriptum (LC) is a rare, superficial, cutaneous lymphatic malformation. ...OBJECTIVES: To systematically review the efficacy and safety of the CO2 laser for the treatment of LC. METHODS: The terms "lymphangioma circumscriptum" and "mic …
BACKGROUND: Lymphangioma circumscriptum (LC) is a rare, superficial, cutaneous lymphatic malformation. ...OBJECTIVES: To systematical …
OK-432 therapy in 64 patients with lymphangioma.
Ogita S, Tsuto T, Nakamura K, Deguchi E, Iwai N. Ogita S, et al. J Pediatr Surg. 1994 Jun;29(6):784-5. doi: 10.1016/0022-3468(94)90370-0. J Pediatr Surg. 1994. PMID: 8078021
Intralesional injection of OK-432 was employed to treat 64 lymphangiomas between 1986 and 1992. This was used as primary therapy for 46 lesions (group A), as treatment following incomplete surgical removal in 14 (group B), and as therapy after failure of bleomycin in 4 (gr …
Intralesional injection of OK-432 was employed to treat 64 lymphangiomas between 1986 and 1992. This was used as primary therapy for …
A case of extensive acquired progressive lymphangioma.
Larkin SC, Wentworth AB, Lehman JS, Tollefson MM. Larkin SC, et al. Pediatr Dermatol. 2018 Jul;35(4):486-489. doi: 10.1111/pde.13486. Epub 2018 Apr 6. Pediatr Dermatol. 2018. PMID: 29633311
Acquired progressive lymphangioma (benign lymphangioendothelioma) is a rare lymphatic anomaly of unclear pathogenesis. ...This report describes a unique case of extensive acquired progressive lymphangioma involving the abdomen, genitalia, and lower extremity of a 1- …
Acquired progressive lymphangioma (benign lymphangioendothelioma) is a rare lymphatic anomaly of unclear pathogenesis. ...This report …
Multifocal lymphangioendotheliomatosis with thrombocytopenia.
Yeung J, Somers G, Viero S, Pope E. Yeung J, et al. J Am Acad Dermatol. 2006 May;54(5 Suppl):S214-7. doi: 10.1016/j.jaad.2005.07.029. J Am Acad Dermatol. 2006. PMID: 16631943
This condition manifests as diffuse congenital vascular lesions in the skin and gastrointestinal tract leading to severe gastrointestinal bleeding and thrombocytopenia. ...
This condition manifests as diffuse congenital vascular lesions in the skin and gastrointestinal tract leading to severe gastrointest …
69 results